Dorzolamide/Timolol EG 20 mg/ml - 5 mg/ml eye drops sol. dropper cont. بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dorzolamide/timolol eg 20 mg/ml - 5 mg/ml eye drops sol. dropper cont.

eg sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; dorzolamide hydrochloride 22,26 mg/ml - eq. dorzolamide 20 mg/ml - eye drops, solution - 20 mg/ml - 5 mg/ml - timolol maleate 6.83 mg/ml; dorzolamide hydrochloride 22.26 mg/ml - timolol, combinations

Dorzolamide/Timolol Sandoz 20 mg/ml - 5 mg/ml  eye drops sol. dropper cont. بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dorzolamide/timolol sandoz 20 mg/ml - 5 mg/ml eye drops sol. dropper cont.

sandoz sa-nv - dorzolamide hydrochloride 22,26 mg/ml - eq. dorzolamide 20 mg/ml; timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml - eye drops, solution - 20 mg/ml - 5 mg/ml - dorzolamide hydrochloride 22.26 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

COSOPT- dorzolamide hydrochloride and timolol maleate solution/ drops الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

cosopt- dorzolamide hydrochloride and timolol maleate solution/ drops

akorn - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - dorzolamide 20 mg in 1 ml - cosopt® is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target iop determined after multiple measurements over time). the iop-lowering of cosopt administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see clinical studies (14)]. cosopt is contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease [see warnings and precautions (5.1)]. cosopt is contraindicated in patients with sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure, and cardiogenic shock [see warnings and precautions (5.2)]. cosopt is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.3)]. teratogen

DORZOLAMIDE-TIMOLOL SOLUTION كندا - الإنجليزية - Health Canada

dorzolamide-timolol solution

alcon canada inc - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 2.0%; 0.5% - dorzolamide (dorzolamide hydrochloride) 2.0%; timolol (timolol maleate) 0.5% - beta-adrenergic agents

MYLAN-DORZOLAMIDE/TIMOLOL SOLUTION كندا - الإنجليزية - Health Canada

mylan-dorzolamide/timolol solution

mylan pharmaceuticals ulc - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 20mg; 5mg - dorzolamide (dorzolamide hydrochloride) 20mg; timolol (timolol maleate) 5mg - beta-adrenergic agents

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION كندا - الإنجليزية - Health Canada

dorzolamide hydrochloride and timolol maleate ophthalmic solution

bausch & lomb inc - timolol (timolol maleate); dorzolamide (dorzolamide hydrochloride) - solution - 5mg; 20mg - timolol (timolol maleate) 5mg; dorzolamide (dorzolamide hydrochloride) 20mg - beta-adrenergic agents

DORZOLAMIDE HYDROCHLORIDE solution/ drops الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

dorzolamide hydrochloride solution/ drops

a-s medication solutions - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml - dorzolamide hydrochloride ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. dorzolamide hydrochloride is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.1) ]. teratogenic effects. pregnancy category c. developmental toxicity studies with dorzolamide hydrochloride in rabbits at oral doses of ≥ 2.5 mg/kg/day revealed malformations of the vertebral bodies. these malformations occurred at doses that caused metabolic acidosis with decreased body weight gain in dams and decreased fetal weights. no treatment-related malformations were seen at 1 mg/kg/day. these doses represent estimated plasma cmax levels in rabbits, 37 and 15 times higher than the lower limit of detection in human plasma following ocular administration, respectively. there are no adequate and well-controlled studies in pregnant women. dorzolamide hydrochloride should be used during pre

JAMP DORZOLAMIDE-TIMOLOL SOLUTION كندا - الإنجليزية - Health Canada

jamp dorzolamide-timolol solution

jamp pharma corporation - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 20mg; 5mg - dorzolamide (dorzolamide hydrochloride) 20mg; timolol (timolol maleate) 5mg - beta-adrenergic agents

VAN-DORZOLAMIDE-TIMOLOL SOLUTION كندا - الإنجليزية - Health Canada

van-dorzolamide-timolol solution

vanc pharmaceuticals inc - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 20mg; 5mg - dorzolamide (dorzolamide hydrochloride) 20mg; timolol (timolol maleate) 5mg - beta-adrenergic agents